Contributors |
|
xiii | |
Acknowledgments and dedication |
|
xvii | |
Obituary |
|
xix | |
|
1 The importance of decontamination in hospitals and healthcare |
|
|
1 | (24) |
|
|
|
1 | (1) |
|
1.2 Microbial resistance and infection control |
|
|
2 | (4) |
|
1.3 Maintaining safe water provision |
|
|
6 | (2) |
|
1.4 Issues of prion transmissibility in healthcare |
|
|
8 | (6) |
|
|
14 | (1) |
|
|
15 | (1) |
|
|
15 | (10) |
|
2 The history of decontamination in hospitals |
|
|
25 | (20) |
|
|
|
|
25 | (1) |
|
2.2 Healthcare-acquired infection |
|
|
26 | (2) |
|
2.3 Key figures in decontamination control |
|
|
28 | (3) |
|
2.4 Heat for sterilization and disinfection |
|
|
31 | (7) |
|
2.5 Chemical disinfectants |
|
|
38 | (2) |
|
2.6 Testing disinfectant activity |
|
|
40 | (1) |
|
2.7 European medical devices directives |
|
|
41 | (1) |
|
2.8 Incidents of contamination as a result of human error |
|
|
42 | (1) |
|
|
43 | (1) |
|
|
43 | (1) |
|
|
43 | (1) |
|
|
44 | (1) |
|
3 Quality and supply of water used in hospitals |
|
|
45 | (26) |
|
|
|
|
45 | (2) |
|
3.2 Compliance in the healthcare environment |
|
|
47 | (2) |
|
3.3 Water treatment and water purification technology |
|
|
49 | (9) |
|
3.4 Water quality monitoring |
|
|
58 | (1) |
|
3.5 Specialist departments and their unique requirements for water quality control |
|
|
59 | (1) |
|
3.6 Sustainability and conservation in healthcare water management |
|
|
59 | (1) |
|
3.7 Conclusion and future trends |
|
|
60 | (1) |
|
|
61 | (8) |
|
|
69 | (2) |
|
4 Control of Legionella in hospital potable water systems |
|
|
71 | (30) |
|
|
|
|
|
71 | (2) |
|
4.2 Systemic disinfection methods |
|
|
73 | (11) |
|
4.3 Emergency disinfection methods |
|
|
84 | (1) |
|
4.4 Selection and validation of disinfection method |
|
|
84 | (4) |
|
4.5 Regulatory requirements, standards, and guidelines |
|
|
88 | (2) |
|
|
90 | (1) |
|
|
90 | (11) |
|
5 Waterborne transmission of Pseudomonas aeruginosa |
|
|
101 | (14) |
|
|
|
|
|
5.1 Pseudomonas aeruginosa |
|
|
101 | (1) |
|
5.2 P. aeruginosa microbiology and pathogenicity |
|
|
101 | (1) |
|
5.3 Epidemiology and infections |
|
|
102 | (1) |
|
5.4 Environmental reservoir and nosocomial outbreaks |
|
|
103 | (1) |
|
5.5 What clinical settings and patient populations are affected by P. aeruginosa? |
|
|
104 | (1) |
|
5.6 What are the potential sources of P. aeruginosa within hospitals? |
|
|
104 | (2) |
|
5.7 What are the potential transmission routes for P. aeruginosa outbreaks? |
|
|
106 | (1) |
|
5.8 What control measures can be implemented to stop P. aeruginosa outbreaks? |
|
|
107 | (1) |
|
5.9 Infection prevention measures |
|
|
107 | (3) |
|
|
110 | (1) |
|
|
110 | (5) |
|
6 Mycobacteria chimaera infections and their transmission from heater-cooler units |
|
|
115 | (20) |
|
|
6.1 Introduction and background |
|
|
115 | (1) |
|
6.2 Waterborne nontuberculous mycobacteria (NTM) |
|
|
115 | (2) |
|
6.3 NTM transmission routes |
|
|
117 | (1) |
|
6.4 What is a heater cooler device? |
|
|
118 | (1) |
|
6.5 How are waterborne pathogens able to grow within HCUs? |
|
|
118 | (3) |
|
6.6 How was M. chimaera transmitted from the HCU to the patients? |
|
|
121 | (1) |
|
6.7 Clinical features and diagnosis |
|
|
122 | (1) |
|
6.8 Manufacturer's instructions for the decontamination of microorganisms in HCUs |
|
|
123 | (1) |
|
6.9 Compatibility of manufacturer's equipment |
|
|
124 | (1) |
|
6.10 Decontamination, containment, or relocation of HCUs |
|
|
125 | (1) |
|
6.11 Implications for ECMO equipment |
|
|
126 | (1) |
|
|
127 | (1) |
|
|
127 | (8) |
|
7 Decontamination of hand washbasins and traps in hospitals |
|
|
135 | (28) |
|
|
|
|
|
|
7.1 Water and wastewater networks in healthcare facilities |
|
|
135 | (2) |
|
7.2 Hand washbasins in the healthcare environment |
|
|
137 | (4) |
|
7.3 Nosocomial infection associated with washbasin traps |
|
|
141 | (1) |
|
7.4 Approaches used to minimize contamination of washbasin traps |
|
|
142 | (11) |
|
7.5 Cleaning of hand washbasins |
|
|
153 | (1) |
|
|
154 | (1) |
|
|
154 | (9) |
|
8 Infection control in Europe |
|
|
163 | (28) |
|
|
|
163 | (2) |
|
8.2 Data available in Europe |
|
|
165 | (4) |
|
8.3 Standards for structures and organizations |
|
|
169 | (11) |
|
8.4 Training of personnel |
|
|
180 | (4) |
|
8.5 Conclusion and future trends |
|
|
184 | (1) |
|
|
185 | (1) |
|
|
186 | (1) |
|
|
186 | (5) |
|
9 The role of the nurse in decontamination |
|
|
191 | (18) |
|
|
|
191 | (1) |
|
9.2 Regulatory standards and decontamination |
|
|
191 | (1) |
|
|
192 | (1) |
|
9.4 Challenges associated with nursing and decontamination of the patient care environment |
|
|
193 | (4) |
|
9.5 Provision of cleaning services |
|
|
197 | (1) |
|
9.6 Management of cleaning services |
|
|
198 | (5) |
|
9.7 Decontamination of patient equipment |
|
|
203 | (3) |
|
|
206 | (1) |
|
9.9 Sources of further information and advice |
|
|
207 | (1) |
|
|
207 | (1) |
|
|
208 | (1) |
|
10 The role of protective clothing in healthcare and its decontamination |
|
|
209 | (18) |
|
|
|
|
209 | (2) |
|
|
211 | (2) |
|
|
213 | (1) |
|
|
214 | (4) |
|
10.5 Cleansing and disposal |
|
|
218 | (3) |
|
10.6 Conclusions and future trends |
|
|
221 | (1) |
|
|
222 | (4) |
|
|
226 | (1) |
|
11 Cleaning and decontamination of the healthcare environment |
|
|
227 | (14) |
|
|
|
|
227 | (1) |
|
11.2 Pathogens survive in the healthcare environment |
|
|
227 | (1) |
|
11.3 Evidence that contaminated surfaces contribute to transmission of hospital pathogens |
|
|
228 | (1) |
|
11.4 Key components of a successful environmental cleaning program |
|
|
229 | (6) |
|
|
235 | (1) |
|
|
235 | (6) |
|
12 Biocides and decontamination agents including sporicides for decontamination in hospitals |
|
|
241 | (18) |
|
|
|
|
241 | (3) |
|
12.2 Currently available biocides and sporicides for use in healthcare and their limitations |
|
|
244 | (4) |
|
12.3 Testing standards for actives and sporicides |
|
|
248 | (5) |
|
12.4 Incidence of resistance and risk to the hospital patient |
|
|
253 | (1) |
|
12.5 Strengths/weaknesses of different disinfectants for a range of microorganisms |
|
|
254 | (1) |
|
|
255 | (1) |
|
12.7 Sources of further information and advice |
|
|
256 | (1) |
|
|
256 | (3) |
|
13 The role of antimicrobial surfaces in hospitals to reduce healthcare-associated infections (HAIs) |
|
|
259 | (42) |
|
|
|
259 | (1) |
|
13.2 Relevance of the built environment to HAIs |
|
|
260 | (2) |
|
13.3 Antimicrobial surfaces |
|
|
262 | (1) |
|
13.4 Antiadhesive surfaces |
|
|
262 | (3) |
|
13.5 Nature inspired antifouling surfaces |
|
|
265 | (3) |
|
13.6 Nature inspired antibacterial surfaces |
|
|
268 | (1) |
|
13.7 Antimicrobial coatings |
|
|
269 | (1) |
|
13.8 Antimicrobial coatings---Triclosan |
|
|
269 | (3) |
|
13.9 Antimicrobial coatings---Utility of bacteriophages |
|
|
272 | (2) |
|
13.10 Antimicrobial coatings---Silver surfaces |
|
|
274 | (5) |
|
13.11 Light-activated antimicrobial surfaces |
|
|
279 | (2) |
|
13.12 Antimicrobial coatings---Copper surfaces |
|
|
281 | (5) |
|
13.13 Continuous microbial debulking of the environment mitigates HAI risk |
|
|
286 | (1) |
|
13.14 Perspectives---A role for antimicrobial surfaces in hospitals to reduce hospital-acquired infections |
|
|
287 | (1) |
|
|
288 | (11) |
|
|
299 | (2) |
|
14 Use of gaseous decontamination technologies for wards and isolation rooms in hospitals and healthcare settings |
|
|
301 | (22) |
|
|
|
|
301 | (2) |
|
14.2 Challenges and considerations for gaseous decontamination in a healthcare setting |
|
|
303 | (6) |
|
14.3 Validation methods to determine efficacy |
|
|
309 | (3) |
|
14.4 Practical use of gaseous decontamination in hospitals |
|
|
312 | (5) |
|
14.5 Conclusion and future trends |
|
|
317 | (1) |
|
14.6 Sources of further information and advice |
|
|
318 | (1) |
|
|
318 | (5) |
|
15 An overview of automated room disinfection systems: When to use them and how to choose them |
|
|
323 | (48) |
|
|
|
|
|
|
323 | (1) |
|
15.2 Why consider an ARD system? |
|
|
323 | (2) |
|
15.3 What level of surface contamination is a risk for transmission? |
|
|
325 | (1) |
|
15.4 Limitations of conventional cleaning and disinfection |
|
|
326 | (2) |
|
15.5 Overview of ARD systems |
|
|
328 | (25) |
|
15.6 When to consider an ARD system |
|
|
353 | (2) |
|
15.7 Using, validating, and regulating ARD systems |
|
|
355 | (2) |
|
15.8 Sources of further information and advice |
|
|
357 | (1) |
|
|
357 | (1) |
|
|
358 | (1) |
|
|
358 | (13) |
|
16 Testing strategies and international standards for disinfectants |
|
|
371 | (6) |
|
|
|
371 | (1) |
|
16.2 Selecting the standards to test against |
|
|
372 | (1) |
|
16.3 Design of test procedures |
|
|
372 | (1) |
|
16.4 Measuring different applications of disinfectants. Surface, hand, instrument, mechanical action, and zonal disinfection |
|
|
373 | (1) |
|
16.5 Europe, Middle East, Africa, and the rest of the world |
|
|
373 | (1) |
|
16.6 USA and the Americas |
|
|
374 | (1) |
|
|
374 | (1) |
|
|
374 | (1) |
|
|
375 | (1) |
|
|
375 | (1) |
|
|
375 | (2) |
|
17 The role of standards in decontamination |
|
|
377 | (18) |
|
|
|
377 | (1) |
|
17.2 Relationship of standards to law and guidance |
|
|
377 | (3) |
|
17.3 Key aims and principles of standards |
|
|
380 | (1) |
|
|
380 | (1) |
|
|
381 | (1) |
|
|
381 | (1) |
|
17.7 International standards |
|
|
382 | (1) |
|
17.8 How standards are drafted |
|
|
383 | (2) |
|
17.9 How to read and understand a standard |
|
|
385 | (2) |
|
17.10 Accessing the most relevant standards and guidance documents |
|
|
387 | (1) |
|
17.11 Conclusion and future trends |
|
|
387 | (1) |
|
Sources of further information and advice |
|
|
388 | (1) |
|
Appendix 1 Standards in decontamination |
|
|
388 | (5) |
|
|
393 | (2) |
|
18 Decontamination of prions |
|
|
395 | (24) |
|
|
|
|
395 | (1) |
|
18.2 Prion diseases: Transmissible spongiform encephalopathies (TSEs) |
|
|
395 | (2) |
|
|
397 | (1) |
|
18.4 Clinical transmission risks |
|
|
398 | (2) |
|
18.5 Decontamination investigations |
|
|
400 | (11) |
|
|
411 | (1) |
|
|
412 | (6) |
|
|
418 | (1) |
|
19 Decontamination of dental devices in the hospital and general dental practice setting |
|
|
419 | (24) |
|
|
|
419 | (1) |
|
19.2 Historic background of dental surgery |
|
|
420 | (1) |
|
19.3 Evidence of infections associated with dentistry |
|
|
420 | (1) |
|
19.4 The role of vCJD in raising standards |
|
|
421 | (3) |
|
19.5 Challenges associated with dental instrument decontamination |
|
|
424 | (2) |
|
19.6 Instrument decontamination processes for dental surgery |
|
|
426 | (3) |
|
19.7 Centralization of dental instrument reprocessing |
|
|
429 | (3) |
|
19.8 Quality management systems |
|
|
432 | (4) |
|
|
436 | (1) |
|
|
437 | (1) |
|
19.11 Sources of further information and advice |
|
|
437 | (1) |
|
|
438 | (4) |
|
|
442 | (1) |
|
20 An overview of current surgical instrument and other medical device decontamination practices |
|
|
443 | (40) |
|
|
20.1 Introduction and background to central decontamination units (CDUs) |
|
|
443 | (1) |
|
20.2 Purpose of decontamination practice of surgical instruments in CDUs |
|
|
444 | (2) |
|
20.3 Current regulations, standards, and guidance |
|
|
446 | (11) |
|
20.4 Risk minimization strategy |
|
|
457 | (2) |
|
20.5 Decontamination process |
|
|
459 | (10) |
|
20.6 Activities impacting on the decontamination process and the quality of sterile instruments |
|
|
469 | (3) |
|
|
472 | (2) |
|
|
474 | (8) |
|
|
482 | (1) |
|
21 Efficacy of current and novel cleaning technologies (ProReveal) for assessing protein contamination on surgical instruments |
|
|
483 | (20) |
|
|
|
|
483 | (3) |
|
21.2 General principles of protein detection |
|
|
486 | (1) |
|
21.3 Current general methods of protein detection (ninhydrin, Biuret, dyes): Sensitivity, specificity, and validation |
|
|
487 | (4) |
|
21.4 Methods of protein detection based on fluorescence |
|
|
491 | (7) |
|
21.5 Other possible technologies |
|
|
498 | (1) |
|
21.6 Strengths and weaknesses of new technologies |
|
|
498 | (2) |
|
|
500 | (1) |
|
|
500 | (3) |
|
22 Decontamination of flexible endoscopes |
|
|
503 | (16) |
|
|
|
503 | (1) |
|
22.2 Structure of endoscopes |
|
|
503 | (1) |
|
|
504 | (2) |
|
22.4 Flexible endoscope decontamination |
|
|
506 | (1) |
|
22.5 Decontamination process |
|
|
506 | (2) |
|
22.6 Decontamination of duodenoscopes |
|
|
508 | (1) |
|
|
509 | (1) |
|
|
510 | (1) |
|
|
510 | (1) |
|
22.10 Endoscopy accessories |
|
|
511 | (1) |
|
22.11 Tracking and traceability |
|
|
511 | (1) |
|
|
512 | (1) |
|
|
512 | (1) |
|
22.14 Extrinsic recontamination |
|
|
512 | (1) |
|
22.15 Intrinsic recontamination |
|
|
513 | (1) |
|
22.16 Storage of endoscopes |
|
|
513 | (1) |
|
22.17 Design of decontamination facilities |
|
|
514 | (3) |
|
22.18 Reasons for decontamination failure |
|
|
517 | (1) |
|
|
517 | (2) |
|
23 Sterilization of flexible endoscopes |
|
|
519 | (12) |
|
|
|
23.1 Introduction: Key principles of sterilizing flexible endoscopes |
|
|
519 | (1) |
|
23.2 Why sterilize flexible endoscopes? |
|
|
520 | (1) |
|
23.3 Problems associated with sterilization of flexible endoscopes |
|
|
521 | (1) |
|
23.4 Methods used in the sterilization of endoscopes |
|
|
522 | (3) |
|
23.5 Testing effectiveness and application of standards |
|
|
525 | (1) |
|
|
525 | (1) |
|
23.7 Biological indicators (BI) |
|
|
525 | (1) |
|
|
526 | (1) |
|
23.9 Example of an "in use" application |
|
|
526 | (1) |
|
|
526 | (1) |
|
Sources of further information |
|
|
527 | (1) |
|
|
527 | (2) |
|
|
529 | (2) |
|
24 Future trends in decontamination in hospitals and healthcare |
|
|
531 | (24) |
|
|
|
531 | (1) |
|
24.2 The future of antibiotic resistance |
|
|
531 | (1) |
|
24.3 Decontamination in water systems |
|
|
532 | (1) |
|
24.4 Use of biocides in water systems |
|
|
533 | (1) |
|
24.5 Use of point of use filters |
|
|
533 | (1) |
|
24.6 Use of TMVs and design and use of outlets |
|
|
534 | (1) |
|
24.7 Exogenous contamination of water outlets |
|
|
534 | (1) |
|
24.8 Role of drains in the spread of infections |
|
|
535 | (1) |
|
24.9 Risks from medical equipment such as heater coolers |
|
|
536 | (1) |
|
24.10 Microorganisms in the built environment |
|
|
536 | (1) |
|
24.11 Control of microorganisms in the built environment |
|
|
537 | (1) |
|
|
538 | (1) |
|
24.13 Hand contact sites and environmental cleaning |
|
|
538 | (1) |
|
|
539 | (1) |
|
24.15 Automated decontamination systems in the built environment |
|
|
540 | (1) |
|
24.16 Decontamination of prions |
|
|
541 | (2) |
|
24.17 Guidance and the rapid detection of protein on surgical instruments |
|
|
543 | (1) |
|
|
544 | (11) |
Index |
|
555 | |